MUC1 and interstitial lung disease: Consistent with our findings, Kamiya et al. showed that pSS–ILD patients with higher levels of serum KL-6 (> 800U/mL) had a higher pulmonary mortality rate compared to those without elevated serum KL-6 levels [34].